Index

Who Requires Dog Testing — And Who's Moving Away

Country-by-country comparison of how beagle testing is regulated, from the EU's mandatory pre-authorization to Japan's voluntary self-regulation. The differences in oversight, transparency, and housing standards are stark.

42,880
dogs in US
FY2024 USDA data
8,709
dogs in EU
2022 — down 16.2%
2,646
UK procedures
2024 — lowest ever
9x
floor space gap
EU vs US minimum
4.7 sq ft
US minimum (USDA)
vs
43 sq ft
EU minimum (Dir. 2010/63)
Source: USDA AWA / EU Directive 2010/63 Annex III
Key Finding
The EU requires nearly 10 times more floor space per dog than the US. EU dogs must be socially housed with a maximum 4-hour isolation period. US regulations set no maximum isolation duration and do not require social housing.

The EU operates under Directive 2010/63/EU, the most comprehensive animal testing regulatory framework in the world. Every beagle study requires government pre-authorization — not just institutional self-approval.

A mandatory harm-benefit analysis must demonstrate that the expected scientific benefit outweighs the harm to the animals. This is not a checkbox exercise — applications are reviewed by national competent authorities with the power to reject studies.

Housing standards are dramatically higher than in the US. The EU mandates a minimum of 4.0 m² per dog (43 sq ft) — compared to the US minimum of 0.88 m² (4.7 sq ft for a beagle-sized dog). Social housing is mandatory, with a maximum of 4 hours of isolation permitted.

In 2022, 8,709 dogs were used across the EU-27 — a 16.2% decline from 2021. Severity classification data shows: 44.7% mild, 32% moderate, and 9.2% severe. Member states publish annual statistics and non-technical summaries of every authorized project — a level of transparency that exists nowhere else.

Key facts
FrameworkDirective 2010/63/EU
Pre-authorizationGovernment approval required for EVERY beagle study
Floor space4.0 m² minimum per dog (43 sq ft)
Social housingMandatory — max 4 hours isolation
Dogs (2022)8,709 in EU-27 — down 16.2% from 2021
Severity44.7% mild, 32% moderate, 9.2% severe
TransparencyAnnual public statistics + non-technical summaries